Rein Therapeutics, Inc. Gain (Loss) on Disposition of Assets
Rein Therapeutics, Inc. (RNTX) reported Gain (Loss) on Disposition of Assets of -$16.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-10-13.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2023-10-13
- Rein Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2023-09-30 was $0.00.
- Rein Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2023-06-30 was $0.00.
- Rein Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2023-03-31 was -$16.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-13 | $0.00 derived: sum of 2 quarters · filed 2023-10-13 | -$16.00K 10-Q · filed 2023-10-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$16.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | -$16.00K 10-Q · filed 2023-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |